Dawnzera (donidalorsen) usage and dosage
After being developed and marketed, Dawnzera (donidalorsen) is a drug that prevents hereditary angioedema (HAE) attacks. It is mainly used for adults and children aged 12 years and above. Its usage and dosage need to strictly follow relevant guidance to ensure the safety and effectiveness of the treatment.
The recommended dose of Dawnzera is 80 mg subcutaneously every 4 weeks. For some patients, physicians may consider a dose of 80 mg subcutaneously every 8 weeks on an individual basis. This flexible dosing regimen can adjust the treatment frequency according to the patient's specific needs and changes in condition, aiming to minimize the frequency of HAE attacks and improve the patient's quality of life.
If a patient misses a dose of Dawnzera within the prescribed time periodThe dose should be refilled as soon as possible. In the meantime, patients should resume treatment at the recommended dosing frequency starting from the date of the most recent dose. This ensures that the drug maintains the appropriate concentration in the body for optimal preventive effect. If the missed dose is close to the time of the next dose, the missed dose should be skipped and the dose should be continued as scheduled. Do not repeat the dose within a short period of time to avoid potential overdose.
Dawnzera is administered as a subcutaneous injection, and patients can choose to self-administer the drug or have it administered by a caregiver. Prior to initiating treatment, the physician or nursing staff will educate the patient and/or caregiver on the proper preparation of the Dawnzera auto-injector and subcutaneous injection technique. This training is important to ensure that injections are administered correctly, reduce discomfort, and reduce potential side effects.
The subcutaneous injection site for Dawnzera can be the abdomen or upper thigh area. The back of the upper arm is also an optional injection site if the injection is administered by a caregiver or health care provider. In order to reduce discomfort at the injection site, it is recommended to choose different sites for administration at different injection times.
Reference materials:https://www.drugs.com/dawnzera.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)